Neoadjuvant pembrolizumab-carboplatin-paclitaxel in locally advanced squamous cell carcinoma of the oral cavity: A case report and literature review
Head and neck cancers are being diagnosed more frequently in elderly patients and at advanced stages. In these cases, standard treatment methods are often not feasible due to patient frailty and malnutrition. A few trials have demonstrated the safety and effectiveness of immune checkpoint inhibitors...
Saved in:
Main Authors: | Abdulrahman Hesham, Fawaz AlOtaibi, D. David Kim, Yousef Alshamrani, Joao Hyppolito, Katie Jubala |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-09-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024004424 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case report of successful treatment of advanced thymic squamous cell carcinoma with poor performance status using multimodal therapy
by: Xianhua Xu, et al.
Published: (2025-01-01) -
Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort
by: Wei-Xiang Qi, et al.
Published: (2025-01-01) -
Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols
by: Sattar Saima, et al.
Published: (2019-03-01) -
L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
by: Seoeun Oh, et al.
Published: (2024-12-01) -
Genetic Variations Affect Chemotherapy Outcomes: A Role of the Spindle-assembly Checkpoint
by: Sinjini Sarkar, et al.
Published: (2024-04-01)